Post by Bio-Rad Laboratories

Transfusion labs are being asked to do more with less every day. ​ ​ As demands increase, many labs are balancing workflow efficiency, staffing pressures, and the need for reliable results — all while supporting critical patient care decisions. ​ ​ At ISBT 2026, Bio-Rad will share how integrated workflow solutions can help support greater efficiency and confidence in the lab, including new extended phenotyping ID-Cards, and a recently published international multicenter evaluation of resolving Daratumumab interferences. ​ We’ll also host a symposium exploring Advances in Feto-Maternal Red Cell Alloimmunization: From Diagnosis to Policy, featuring Prof. Masja de Haas and Dr. Nor Hafizah Ahmad.​ https://lnkd.in/eH39TYUv